Skip to main content
    D

    DarioHealth Corp (DRIO)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.15
    -0.11 (-8.73%)

    Market Cap: $14.22M

    Last updated: Nov 17, 2026 at 10:57 AM ET

    DarioHealth Corp (DRIO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    DarioHealth reported revenue of $22.36M for the fiscal year ended Dec 31, 2025, down 17.3% from the year before. That year, net income was -$41.71M with a net margin of -186.6%, operating cash flow was -$25.94M and free cash flow was -$26.08M. The quarter ended Sep 30, 2026 had revenue of $5.31M and net income of -$8.85M.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue grew from $2.80M, a compound annual rate of 26.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$22.36M-17.3%56.6%-163.9%-186.6%
    Dec 2024$27.04M+32.9%49.1%-213.6%-158.1%
    Dec 2023$20.35M-26.4%29.4%-276.1%-292.0%
    Dec 2022$27.66M+34.8%34.9%-205.4%-224.9%
    Dec 2021$20.51M+170.8%19.3%-372.9%-374.2%
    Dec 2020$7.58M+0.2%33.2%-394.7%-388.7%
    Dec 2019$7.56M+2.2%34.4%-234.2%-234.6%
    Dec 2018$7.39M+43.0%23.9%-239.2%-240.8%
    Dec 2017$5.17M+84.4%25.4%-278.9%-304.5%
    Dec 2016$2.80MN/A-29.6%-396.0%-388.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$22.36M$27.04M$20.35M$27.66M$20.51M$7.58M$7.56M$7.39M$5.17M$2.80M
    Cost of revenue$9.69M$13.77M$14.37M$18.00M$16.55M$5.06M$4.96M$5.63M$3.86M$3.63M
    Gross profit$12.66M$13.27M$5.98M$9.65M$3.96M$2.51M$2.60M$1.76M$1.31M-$830.00K
    Research and development$13.79M$24.18M$20.25M$19.65M$17.22M$4.43M$3.69M$3.68M$3.30M$2.15M
    Operating income-$36.66M-$57.74M-$56.19M-$56.81M-$76.49M-$29.90M-$17.70M-$17.69M-$14.42M-$11.10M
    Net income-$41.71M-$42.75M-$59.43M-$62.19M-$76.76M-$29.45M-$17.74M-$17.80M-$15.74M-$10.89M
    EBITDA-$35.45M-$37.17M-$53.18M-$53.42M-$72.04M-$29.25M-$17.52M-$17.60MN/A-$10.50M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$5.31M$5.18M$5.58M$5.23M$5.01M$5.37M$6.75M$7.60M$7.42M$6.25M$5.76M$3.62M
    Gross profit$3.15M$3.19M$3.20M$2.80M$3.02M$2.96M$3.88M$4.20M$3.88M$2.76M$2.43M$132.00K
    Operating income-$8.04M-$6.48M-$7.31M-$8.56M-$9.48M-$9.20M-$9.41M-$11.67M-$12.03M-$16.19M-$17.86M-$14.21M
    Net income-$8.85M-$7.92M-$8.25M-$9.03M-$10.47M-$12.99M-$9.23M-$9.63M-$12.33M-$13.61M-$7.17M-$14.29M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $31.18M exceeded cash and equivalents by $9.37M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$110.08M$118.88M$96.39M$119.19M$100.77M$35.41M$24.57M$14.09M$6.96M$3.87M
    Current assets$35.07M$40.53M$47.33M$65.52M$45.60M$34.13M$22.94M$13.10M$6.05M$2.94M
    Cash and equivalents$21.80M$27.76M$36.80M$49.36M$35.81M$28.59M$20.39M$11.00M$3.72M$1.09M
    Total liabilities$42.15M$46.87M$38.24M$39.19M$15.22M$7.26M$5.67M$5.16M$3.02M$10.41M
    Short-term debt$430.00K$5.45M$3.95M$8.82M$0$310.00K$317.00KN/AN/AN/A
    Long-term debt$30.75M$23.47M$24.59M$18.11M$0N/AN/AN/AN/AN/A
    Shareholder equity$67.92M$72.02M$58.14M$80.00M$85.55M$28.15M$18.89M$8.93M$3.94M-$6.54M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$112.43M$96.59M$103.28M$110.08M$117.73M$108.33M$115.60M$118.88M$109.95M$122.13M$136.96M$96.39M
    Total liabilities$41.16M$41.50M$40.90M$42.15M$42.79M$44.34M$41.90M$46.87M$51.44M$54.08M$58.93M$38.24M
    Cash and equivalents$27.84M$6.63M$14.98M$26.25M$31.91M$21.95M$27.85M$27.76M$15.55M$22.94M$34.37M$36.80M
    Shareholder equity$71.27M$55.09M$62.38M$67.92M$74.93M$63.99M$73.70M$72.02M$58.51M$68.06M$78.03M$58.14M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$25.94M-$38.56M-$30.38M-$47.84M-$50.41M-$17.74M-$15.72M-$11.47M-$10.62M-$8.38M
    Capital expenditures$142.00K$138.00K$584.00K$442.00K$261.00K$118.00K$98.00K$71.00K$195.00K$808.00K
    Free cash flow-$26.08M-$38.70M-$30.96M-$48.29M-$50.67M-$17.85M-$15.82M-$11.54M-$10.81M-$9.19M
    Dividends paidN/AN/AN/A$23.79MN/AN/AN/AN/AN/AN/A
    Share repurchasesN/AN/AN/A$134.00K$0N/AN/AN/AN/AN/A
    Investing cash flow-$4.34M-$8.93M-$547.00K-$573.00K-$8.13M-$1.62M-$113.00K-$72.00K-$219.00K-$947.00K
    Financing cash flow$24.31M$38.53M$18.25M$61.94M$65.77M$27.55M$25.25M$18.74M$13.46M$7.75M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$5.54M-$6.08M-$6.03M-$5.89M-$7.35M-$6.03M-$6.67M-$6.73M-$7.36M-$11.36M-$13.11M-$7.34M
    Capital expenditures$27.00K$38.00K$31.00K$26.00K$41.00K$44.00K$31.00K$21.00K$32.00K$29.00K$56.00K$83.00K
    Free cash flow-$5.57M-$6.12M-$6.06M-$5.91M-$7.39M-$6.08M-$6.70M-$6.75M-$7.39M-$11.39M-$13.17M-$7.42M
    Last 12 quarters

    Frequently Asked Questions About DRIO

    What is DarioHealth's annual revenue?

    DarioHealth reported revenue of $22.36M for the fiscal year ended Dec 31, 2025.

    How fast is DarioHealth's revenue growing?

    Revenue was down 17.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -6.8%.

    Is DarioHealth profitable?

    No. DarioHealth reported net income of -$41.71M for the fiscal year ended Dec 31, 2025, with a net margin of -186.6%.

    How much free cash flow does DRIO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$25.94M minus capital expenditures of $142.00K produced free cash flow of -$26.08M.

    How much debt does DarioHealth have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $30.75M, short-term debt of $430.00K and cash and equivalents of $21.80M.